What are antiplatelet agents primarily used for in clinical practice?

Antiplatelet agents are primarily used in clinical practice to prevent blood clots. These medications work by inhibiting the platelets' ability to clump together and form aggregates, which is a critical step in the formation of blood clots. This action is particularly important in preventing events such as heart attacks and strokes, which can occur when blood flow is obstructed by a clot in the arteries.

By reducing platelet aggregation, antiplatelet agents help maintain proper blood flow and reduce the risk of thrombotic events in patients who may be at increased risk due to various cardiovascular conditions. This makes them key therapeutic agents in the management of patients with a history of cardiovascular disease, those with atherosclerosis, or those who have undergone procedures such as stenting.

Preventing infections, reducing blood pressure, or enhancing cholesterol levels do not directly relate to the primary function of antiplatelet agents, which is focused specifically on the antithrombotic effects to maintain vascular health.